Request from the MPN Foundation for Vietnam Vete... - MPN Voice

MPN Voice

10,784 members14,980 posts

Request from the MPN Foundation for Vietnam Veterans exposed to Agent Orange and who now have a MPN to contact them

Mazcd profile image
MazcdPartnerMPNVoice
0 Replies

MPN Advocacy and Education International is searching for Vietnam Veterans who were exposed to Agent Orange and now have a diagnosis of Myelofibrosis, Polycythemia Vera, or Essential Thrombocythemia (Myeloproliferative Neoplasms-MPNs).

This information will be collected in an attempt to add myeloproliferative neoplasms to the US Department of Veterans Affairs 'presumptive' list of conditions resulting from exposure to Agent Orange/dioxin during the Vietnam War and could create a resource for assistance with treatments and compensation.

MPN Research Foundation is assisting this effort by asking patients who match this description to contact MPN Advocacy and Education International at abrazeau@mpnadvocacy.com or 517.899.6889. This project hopes to also generate interest into further research into the link between myeloproliferative neoplasms and exposure to Agent Orange/dioxin.

Written by
Mazcd profile image
Mazcd
Partner
To view profiles and participate in discussions please or .
Read more about...

Not what you're looking for?

You may also like...

MPN Genetics

Was out looking at some material and came across this presentation about MPN Genetics by Dr. Jerry...

Guidelines Myeloproliferative Neoplasms and Articles of Interest

Hello I have listed some links for MPN articles of interest. Kind regards Anna The 2016 revision to...

Webinar re. MPN Clinical Trials as an Option

Should you consider an MPN clinical trial? In this webinar, Dr. Ruben Mesa will provide an overview...

2022 NCCN Guidelines for MPNs

Another good resource posted by our friends from the MPN Research Foundation. 2022 National...

Second Malignancies Among Older Patients With Classical MPN Treated With Hydroxyurea

TAKE-HOME MESSAGE In this retrospective cohort study of 4023 patients aged ≥66 years with...